Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis

Schmidt C, Stallmach A (2005) Etiology and pathogenesis of inflammatory bowel disease. Minerva Gastroenterol Dietol 51(2):127–145

Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205

Atreya I, Atreya R, Neurath MF (2008) NF-kappaB in inflammatory bowel disease. J Intern Med 263(6):591–596. doi: 10.1111/j.1365-2796.2008.01953.x (Review)

Kaser A, Tilg H (2008) Novel therapeutic targets in the treatment of IBD. Expert Opin Ther Targets 12(5):553–563. doi: 10.1517/14728222.12.5.553

Hanauer SB (1996) Inflammatory bowel disease. N Engl J Med 334(13):841–848. doi: 10.1056/NEJM199603283341307 (Review)

Pari L, Tewas D, Eckel J (2008) Role of curcumin in health and disease. Arch Physiol Biochem 114(2):127–149. doi: 10.1080/13813450802033958 (Review)

Kozuch PL, Hanauer SB (2008) Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol 14(3):354–377. doi: 10.3748/wjg.14.354 (Review)

Billerey-Larmonier C, Uno JK, Larmonier N, Midura AJ, Timmermann B, Ghishan FK, Kiela PR (2008) Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis 14(6):780–793. doi: 10.1002/ibd.20348

Holt PR, Katz S, Kirshoff R (2005) Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 50(11):2191–2193. doi: 10.1007/s10620-005-3032-8

Boone DL, Ma A (2003) Connecting the dots from toll-like receptors to innate immune cells and inflammatory bowel disease. J Clin Invest 111(9):1284–1286

Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197–216. doi: 10.1146/annurev.immunol.20.083001.084359

Bou-Fersen AM, Anim JT, Khan I (2008) Experimental colitis is associated with ultrastructural changes in inflamed and uninflamed regions of the gastrointestinal tract. Med Princ Pract 17(3):190–196. doi: 10.1159/000117791

Al-Jarallah A, Khan I, Oriowo MA (2008) Role of Ca2+-sensitization in attenuated carbachol-induced contraction of the colon in a rat model of colitis. Eur J Pharmacol 579(1–3):365–373. doi: 10.1016/j.ejphar.2007.10.069

Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96(3):795–803

Khan I, Oriowo MA, Anim JT (2005) Amelioration of experimental colitis by Na–H exchanger-1 inhibitor amiloride is associated with reversal of IL-1ss and ERK mitogen-activated protein kinase. Scand J Gastroenterol 40(5):578–585. doi: 10.1080/00365520510012352

Khan I (2002) Antisense inhibition of cyclooxygenase-2 causes a selective suppression of the Na+–H+ exchanger isoform 3 in rat kidney in experimental colitis. Nephron 91(1):120–128. doi: 10.1159/000057613

Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78(3):206–209. doi: 10.1111/1523-1747.ep12506462

Khan I, Al-Awadi FM, Thomas N (2001) In vivo inhibition of cyclooxygenase-2 by a selective phosphorothioated oligonucleotide. Antisense Nucleic Acid Drug Dev 11(4):199–207. doi: 10.1089/108729001317022205

Wang K, Wan YJ (2008) Nuclear receptors and inflammatory diseases. Exp Biol Med (Maywood) 233(5):496–506. doi: 10.3181/0708-MR-231 (Review)

Hogaboam CM, Vallance BA, Kumar A, Addison CL, Graham FL, Gauldie J, Collins SM (1997) Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest 100(11):2766–2776. doi: 10.1172/JCI119823

Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martínez C (2008) VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4. Peptides 29(6):948–956. doi: 10.1016/j.peptides.2008.01.019

Arranz A, Abad C, Juarranz Y, Torroba M, Rosignoli F, Leceta J, Gomariz RP, Martínez C (2006) Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis. Ann N Y Acad Sci 1070:129–134. doi: 10.1196/annals.1317.001

Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, Iiyama R, Totsuka T, Takeda K, Akira S, Watanabe M (2005) MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 40:16–23. doi: 10.1007/s00535-004-1492-9